Tsang Patricia C, Chen Guoli
MedStar Washington Hospital Center, Pathology & Laboratory Medicine, Washington, DC, USA.
Geisinger Medical Laboratories, Geisinger Health, Danville, Pennsylvania, USA.
J Pathol Transl Med. 2022 Mar;56(2):113-114. doi: 10.4132/jptm.2022.01.25. Epub 2022 Mar 11.
Predictive biomarker testing plays a critical role in targeted immuno-oncology, including the use of immune checkpoint inhibitors (ICI) for various solid tumors. Molecular advancements in cancers of the breast, kidney and brain have continued to propel tumor classification and precision therapy.
预测性生物标志物检测在靶向免疫肿瘤学中发挥着关键作用，包括将免疫检查点抑制剂（ICI）用于各种实体瘤。乳腺癌、肾癌和脑癌的分子进展持续推动肿瘤分类和精准治疗。
